Carol Langford
Director, Center for Vasculitis Care and Research · Cleveland Clinic Foundation
Credentials: · · · ·
History
PresentCenter for Vasculitis Care and Research · Cleveland Clinic Foundation
- Present
Center for Vasculitis Care and Research · Cleveland Clinic Outpatient Center A - Austintown
- Present
Institutional Review Board Department · Cleveland Clinic Outpatient Center A - Austintown
1992–1994- 1987–1990
1983–1987- 1979–1983
Research
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism · 2013 · 4,922 citations
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
New England Journal of Medicine · 2010 · 2,067 citations
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine · 2017 · 801 citations
119 papers
92 papers
92 papers
77 papers
- GH
67 papers
- SY
56 papers
55 papers · 1 as a fellow
- JS
51 papers
Grants
- 2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $15.7K · Cleveland Clinic Lerner Com-Cwru
Clinical trials
- 2021–2029
Abatacept for the Treatment of Giant Cell Arteritis
Principal investigator · Recruiting · Phase 3
University of Pennsylvania
- 2015–2023
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Principal investigator · Completed · Phase 3
University of South Florida
- 2008–2015
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Principal investigator · Completed · Phase 2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- 2008–2011
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Principal investigator · Completed · Phase 1, Phase 2
University of Pennsylvania